- Loading stock data...
Financial Analysis of Listed Companies
Invitae (NYSE: NVTA) announced its 2022 Q2 financial results on August 9, 2022. According to the announcement, total revenue was up 17% (3 months, YoY). On the other hand, Invitae recorded asset impairment of 2,318 million USD. As a result, loss from operation and net loss were 2,520 million USD and 2,523 million USD, respectivelyContinue reading “Cash Burn in 2022 Q2 was improved compared to 2022 Q1”
adidas (XETR: ADS.DE) announced its 2022 Q2 financial results on August 4, 2022. According to the announcement, net sales were up 10.2% (3 months, YoY). On the other hand, operating profit and net income were down 27.9% and down 24.2%, respectively. In addition, gross margin was 50.3%, down 1.5 pp (3 months, YoY). The declinesContinue reading “adidas suffered from Supply Chain Constraints in 2022 Q2”
Block announced its 2022 Q2 financial results on August 4, 2022. According to the announcement, total net revenue was down 6% (3 months, YoY). Operating loss and net loss were 214 million USD and 209 million USD, respectively. Meanwhile, gross profit was up 29% (3 months, YoY). Due to Block’s aggressive upfront investment, operating expensesContinue reading “Block is continuously recording Operating Loss and Net Loss”
Mastercard (NYSE: MA) announced its 2022 Q2 financial results on July 28, 2022. According to the announcement, net revenue, operating income and net income were up 21%, up 29% and up 10%, respectively (YoY, 3 months). In this regard, net cash provided by operating activities was up 14% (YoY, 6 months). In addition, free cashContinue reading “Mastercard is recording Double-Digit Growth in 2022 Q2”
Apple (NASDAQ: AAPL) announced its 2022 Q3 financial results on July 28, 2022. According to the announcement, total net sales, operating income and net income were up 2%, down 4% and down 11%, respectively (YoY, 3 months). In this regard, product sales was down 1% and services revenue was up 12%. Looking at sales growthContinue reading “Growth of Service Revenue is continuing in Apple’s 2022 Q3 Results”
Teladoc Health, Inc. (NYSE: TDOC) announced its 2022 Q2 financial results on July 27, 2022. According to the announcement, total revenue was up 18% (YoY, 3 months). On the other hand, Teladoc recorded operating loss and net loss of -3 billion USD each (3 months), due to non-cash goodwill impairment charge, which is related toContinue reading “Teladoc recorded Non-Cash Goodwill Impairment of 3.0 billion USD again”
On November 29th, 2020, we, Watanabe & Brothers’ Investment, visited Tesla Japan Minami Aoyama. At Tesla Japan Minami Aoyama, Model 3 is exhibited. A person in charge (PIC) politely explained the features of Model 3 as well as Tesla’s efforts. Currently, the price of Model 3 is currently about ¥ 5 million. It is moreContinue reading “Tesla is leading in Autopilot Technology”
Food and Drug Administration (FDA) issued an emergency use authorization for Abbott Laboratories’ (NYSE: ABT) BinaxNOWTM COVID-19 Ag. BinaxNOWTM COVID-19 Ag is a card-type tool for rapidly detecting COVID-19 infection in only 15 minutes. According to the press release, Abbott are going to distribute it for $5. BinaxNOWTM COVID-19 Ag is one of antibody testContinue reading “FDA issued Emergency Use Authorization for Abbott’s COVID-19’s Antibody Test Kit”
Important Notice: This webpage was originally prepared in English, and translated into the other languages with plugin utilizing Google Translation API. We hereby notify that the translations are provided only for the sake of reference, and any opinions or statements here should be interpreted in original English.